Prescott, E, Angerås, O, Erlinge, D, Grove, E L, Hedman, M, Jensen, L O, Pernow, J, Saraste, A, Åkerblom, A, Svedlund, S, Rudvik, A, Knöchel, J, Lindstedt, E-L, Garkaviy, P, Gan, L-M & Gabrielsen, A 2022, ' Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction : The phase 2a FLAVOUR study ', International Journal of Cardiology, vol. 365, pp. 34-40 . https://doi.org/10.1016/j.ijcard.2022.07.016 Prescott, E, Angerås, O, Erlinge, D, Grove, E L, Hedman, M, Jensen, L O, Pernow, J, Saraste, A, Åkerblom, A, Svedlund, S, Rudvik, A, Knöchel, J, Lindstedt, E L, Garkaviy, P, Gan, L M & Gabrielsen, A 2022, ' Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction : The phase 2a FLAVOUR study ', International Journal of Cardiology, vol. 365, pp. 34-40 . https://doi.org/10.1016/j.ijcard.2022.07.016